Can timing a pain pill make IUD insertion less painful?

NCT ID NCT06853327

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This study tests whether taking oral ketorolac, a common pain reliever, at different times before an IUD insertion changes how much pain a person feels during the procedure. Researchers will compare pain scores among three groups: those who take the drug two hours before, one hour before, or right at the start. The trial includes adults aged 18 and older who want an IUD, and uses a placebo to keep the comparison fair.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
oral ketorolac (Toradol), a nonsteroidal anti-inflammatory drug, given at different times before IUD insertion
What this could lead to
If giving ketorolac earlier works better, it could offer a simple way to reduce pain during IUD insertion for many people.
What could go wrong
This is a small, early-stage trial, and the drug may not reduce pain more than the current approach. Ketorolac also carries risks like stomach bleeding or kidney issues, though a single low dose is generally safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 108 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years or older * Able to consent * Desires IUD insertion Exclusion Criteria: * IUD placement under sedation or oral anxiolytic * IUD replacement (removal with insertion) * Daily narcotic or NSAID use * Contraindications to IUD placement * Current: pregnancy, genital/pelvic infection * Lifetime history: uterine anomaly, pelvic inflammatory disease, allergy to levonorgestrel or copper * Contraindications to ketorolac * Current: weight under 50 kilograms * Lifetime history: allergy to NSAIDs, liver disease, renal disease, peptic ulcer disease, cerebrovascular bleeding, gastrointestinal bleeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Iud insertion pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of North Carolina - Hillsborough Campus

    Hillsborough, North Carolina, 27278, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.